瘟疫之源对阵 寒冰射手
瘟疫之源 vs 寒冰射手在LoL版本26.11中是a very close对线。瘟疫之源以50.3%胜率(+0.6%)击败寒冰射手，基于346场比赛。寒冰射手 wins the early laning phase while 瘟疫之源 scales better into the late game.下方您将找到瘟疫之源 vs 寒冰射手对线的最佳瘟疫之源出装、符文、对线统计和策略。
瘟疫之源对线分析
使用下拉菜单选择对手，查看瘟疫之源对阵他们的详细分析。您将获得正面对决胜率、对线数据、该对线的最佳出装和符文，以及前期vs后期分析——所有数据均基于真实排位数据。
瘟疫之源 vs 寒冰射手对线谁赢？
瘟疫之源对战寒冰射手对决摘要
瘟疫之源对战寒冰射手在英雄联盟排位赛中是本质上是五五开的对决。根据346场近期比赛的分析，瘟疫之源以50.3%的胜率获胜，相比寒冰射手的49.7%，给予瘟疫之源 0.6个百分点的优势。 游戏阶段动态在此起着关键作用：寒冰射手控制早期对线阶段，但瘟疫之源在游戏进行时成长更好。对决会根据游戏时长发生戏剧性变化——寒冰射手需要在瘟疫之源达到强势期之前压制优势，而瘟疫之源应专注于安全发育和达到关键装备节点。 最显著的统计差距在控制技能方面，寒冰射手领先1.1s CC/min——这一差异严重影响换血和小规模团战的结果。 瘟疫之源有统计优势，但差距足够接近，尊重寒冰射手的优势很重要。在冷却时间有利时换血，追踪敌方打野，并朝着你最强的装备节点构建，将轻微优势转化为决定性领先。 理解这些对决动态对于英雄选择决策和面对该线上对手时的游戏内策略至关重要。
瘟疫之源对战寒冰射手对线阶段分析
瘟疫之源在对线阶段对阵寒冰射手时更有优势，赢得5个关键统计类别中的3个。瘟疫之源在伤害, 金币收入 和 续航方面有优势，使其成为这场对决中更强的对线者。
Best 瘟疫之源 Build Against 寒冰射手
狂战士胫甲是对抗寒冰射手的最佳鞋子选择，提供瘟疫之源在这场对决中最需要的移动速度和属性。 瘟疫之源对抗寒冰射手表现最好的核心装备是无尽之刃, 海克斯镜片 C44 和 猎魔人弩箭。这一组合给瘟疫之源提供了对决所需的伤害、生存和功能的有效平衡。 这套出装表现出色，在1场比赛中达到100.0%胜率——远高于平均水平，使其成为对抗寒冰射手的最佳装备路径。 可能需要根据队伍阵容和游戏状态进行调整，但这套出装为瘟疫之源对战寒冰射手对决提供了最强的基础。
Early Game vs Late Game
瘟疫之源46.6%
寒冰射手53.4%瘟疫之源52.6%寒冰射手47.4%寒冰射手以令人印象深刻的53.4%胜率主导前期（前15分钟）——领先瘟疫之源 6.8个百分点。这一不平衡的前期意味着寒冰射手可以从1级开始决定线上节奏，控制换血、兵线状态和河道优先权。
瘟疫之源在后期（25分钟以上）远远更强，拥有52.6%胜率——比寒冰射手高5.2点。长时间游戏强烈有利于瘟疫之源，其技能组和成长使其成为团战和目标控制中的主导力量。
这场对决有戏剧性的力量转变：寒冰射手必须积极压制早期优势并在瘟疫之源达到成长节点之前结束游戏。如果瘟疫之源在不太落后的情况下度过对线阶段，对决将倾向于他们。龙和峡谷先锋控制至关重要——确保早期目标的队伍可以滚雪球或争取时间成长。
Best 瘟疫之源 Runes Against 寒冰射手
精密
巫术
精密主系配巫术副系的组合帮助瘟疫之源在这场激烈竞争的对决中最大化潜力，提供正确的进攻和防守工具组合来超越寒冰射手。
英雄联盟26.11版本瘟疫之源对线数据。下表显示瘟疫之源对阵当前版本每个英雄的胜率、经济差和表现统计。点击任意英雄名称可查看详细对位分析，包括瘟疫之源最佳出装、符文、对线数据和该对线的前期与后期分析。
对手 | 胜率 | 场次 | CS/分钟 | 伤害/分 | 金币/局 | 前期胜率 | 后期胜率 |
|---|---|---|---|---|---|---|---|
| 47.95% | 440 | 5.6 | 958 | 13,993 | 36.3% | 56.8% | |
| 55.74% | 366 | 5.8 | 967 | 14,165 | 51.0% | 59.3% | |
| 50.29% | 346 | 5.6 | 924 | 14,204 | 46.6% | 52.6% | |
| 45.66% | 346 | 5.3 | 848 | 13,068 | 42.3% | 48.2% | |
| 55.78% | 346 | 5.9 | 1,024 | 14,680 | 58.8% | 53.8% | |
| 52.08% | 336 | 5.8 | 933 | 13,767 | 48.6% | 54.8% | |
| 54.29% | 210 | 5.9 | 930 | 13,910 | 47.1% | 59.2% | |
| 55.50% | 191 | 5.9 | 1,004 | 14,475 | 51.9% | 58.2% | |
| 44.08% | 152 | 5.6 | 836 | 13,350 | 41.2% | 46.4% | |
| 54.05% | 148 | 5.7 | 956 | 14,644 | 54.7% | 53.7% | |
| 50.38% | 131 | 5.6 | 960 | 14,446 | 47.2% | 52.6% | |
| 45.87% | 109 | 5.9 | 867 | 14,013 | 42.9% | 48.3% | |
| 50.47% | 107 | 5.6 | 925 | 13,039 | 50.0% | 50.9% | |
| 40.86% | 93 | 5.3 | 924 | 14,613 | 25.8% | 48.4% | |
| 55.56% | 90 | 5.8 | 914 | 14,179 | 48.7% | 60.8% | |
| 50.65% | 77 | 5.5 | 891 | 13,162 | 39.0% | 63.9% | |
| 59.74% | 77 | 5.6 | 929 | 14,475 | 59.4% | 60.0% | |
| 46.58% | 73 | 6.3 | 1,052 | 15,056 | 30.8% | 55.3% | |
| 55.07% | 69 | 6.0 | 997 | 13,971 | 52.8% | 57.6% | |
| 48.48% | 66 | 5.8 | 972 | 14,260 | 42.3% | 52.5% | |
| 37.10% | 62 | 5.7 | 881 | 13,349 | 38.5% | 36.1% | |
| 46.30% | 54 | 5.8 | 829 | 13,723 | 31.8% | 56.3% | |
| 46.81% | 47 | 5.5 | 918 | 15,339 | 46.7% | 46.9% | |
| 47.73% | 44 | 5.7 | 980 | 14,428 | 41.2% | 51.9% | |
| 36.11% | 36 | 4.6 | 872 | 13,180 | 29.4% | 42.1% | |
| 61.76% | 34 | 5.7 | 1,026 | 15,098 | 63.6% | 60.9% | |
| 48.48% | 33 | 5.8 | 747 | 13,344 | 37.5% | 58.8% | |
| 48.48% | 33 | 5.1 | 766 | 12,692 | 38.5% | 55.0% | |
| 43.75% | 32 | 5.7 | 948 | 14,046 | 26.7% | 58.8% | |
| 53.33% | 30 | 5.8 | 1,083 | 15,201 | 61.5% | 47.1% | |
| 39.13% | 23 | 5.6 | 787 | 12,742 | 16.7% | 63.6% | |
| 45.45% | 22 | 4.5 | 844 | 10,795 | 40.0% | 57.1% | |
| 50.00% | 20 | 5.5 | 1,030 | 13,389 | 66.7% | 42.9% | |
| 55.00% | 20 | 5.8 | 977 | 14,032 | 44.4% | 63.6% | |
| 31.58% | 19 | 4.5 | 916 | 15,500 | 0.0% | 40.0% | |
| 38.89% | 18 | 2.1 | 879 | 12,295 | 50.0% | 35.7% | |
| 70.59% | 17 | 5.6 | 1,018 | 14,445 | 83.3% | 63.6% | |
| 17.65% | 17 | 1.1 | 712 | 12,669 | 25.0% | 11.1% | |
| 52.94% | 17 | 1.9 | 875 | 11,620 | 44.4% | 62.5% | |
| 35.29% | 17 | 4.6 | 849 | 13,831 | 14.3% | 50.0% | |
| 33.33% | 15 | 1.9 | 652 | 10,196 | 57.1% | 12.5% | |
| 33.33% | 15 | 1.4 | 843 | 13,936 | 0.0% | 50.0% | |
| 46.67% | 15 | 1.7 | 827 | 14,024 | 33.3% | 50.0% | |
| 50.00% | 14 | 5.1 | 895 | 12,823 | 50.0% | 50.0% | |
| 71.43% | 14 | 5.8 | 1,085 | 11,810 | 71.4% | 71.4% | |
| 35.71% | 14 | 4.9 | 1,008 | 11,959 | 33.3% | 40.0% | |
| 46.15% | 13 | 1.9 | 876 | 11,717 | 57.1% | 33.3% | |
| 46.15% | 13 | 1.1 | 678 | 11,935 | 50.0% | 42.9% | |
| 30.77% | 13 | 5.9 | 1,049 | 11,184 | 25.0% | 40.0% | |
| 38.46% | 13 | 1.6 | 860 | 13,610 | 75.0% | 22.2% | |
| 66.67% | 12 | 5.8 | 931 | 13,033 | 100.0% | 33.3% | |
| 36.36% | 11 | 4.0 | 774 | 11,150 | 20.0% | 50.0% | |
| 54.55% | 11 | 2.7 | 764 | 13,626 | 40.0% | 66.7% | |
| 63.64% | 11 | 1.7 | 888 | 14,310 | 100.0% | 55.6% | |
| 36.36% | 11 | 1.5 | 953 | 12,232 | 33.3% | 40.0% | |
| 63.64% | 11 | 3.0 | 802 | 8,429 | 50.0% | 100.0% | |
| 40.00% | 10 | 1.1 | 814 | 11,906 | 57.1% | 0.0% | |
| 50.00% | 10 | 5.1 | 860 | 12,019 | 66.7% | 25.0% | |
| 30.00% | 10 | 1.6 | 674 | 11,020 | 28.6% | 33.3% | |
| 70.00% | 10 | 3.9 | 780 | 13,126 | 60.0% | 80.0% | |
| 50.00% | 10 | 2.2 | 755 | 12,834 | 40.0% | 60.0% | |
| 40.00% | 10 | 5.8 | 1,121 | 12,040 | 42.9% | 33.3% | |
| 33.33% | 9 | 3.1 | 908 | 13,698 | 0.0% | 50.0% | |
| 33.33% | 9 | 5.7 | 678 | 9,080 | 60.0% | 0.0% | |
| 22.22% | 9 | 3.8 | 703 | 9,811 | 20.0% | 25.0% | |
| 33.33% | 9 | 1.3 | 955 | 14,428 | 33.3% | 33.3% | |
| 50.00% | 8 | 2.7 | 896 | 13,417 | 0.0% | 80.0% | |
| 62.50% | 8 | 3.1 | 807 | 10,065 | 50.0% | 100.0% | |
| 12.50% | 8 | 5.4 | 826 | 9,824 | 0.0% | 25.0% | |
| 12.50% | 8 | 1.2 | 715 | 11,056 | 20.0% | 0.0% | |
| 57.14% | 7 | 4.8 | 845 | 13,928 | 100.0% | 40.0% | |
| 71.43% | 7 | 1.9 | 845 | 10,724 | 66.7% | 75.0% | |
| 57.14% | 7 | 3.7 | 907 | 10,983 | 60.0% | 50.0% | |
| 28.57% | 7 | 2.3 | 826 | 12,328 | 25.0% | 33.3% | |
| 42.86% | 7 | 1.4 | 1,022 | 14,465 | 100.0% | 33.3% | |
| 57.14% | 7 | 5.6 | 816 | 12,685 | 50.0% | 66.7% | |
| 16.67% | 6 | 2.2 | 780 | 14,435 | 0.0% | 25.0% | |
| 83.33% | 6 | 2.2 | 1,187 | 13,656 | 100.0% | 50.0% | |
| 16.67% | 6 | 5.5 | 797 | 13,435 | 33.3% | 0.0% | |
| 33.33% | 6 | 2.8 | 821 | 13,186 | 33.3% | 33.3% | |
| 33.33% | 6 | 3.8 | 1,185 | 18,825 | 0.0% | 33.3% | |
| 66.67% | 6 | 5.0 | 764 | 10,479 | 33.3% | 100.0% | |
| 60.00% | 5 | 1.7 | 797 | 11,268 | 33.3% | 100.0% | |
| 40.00% | 5 | 1.0 | 684 | 12,588 | 66.7% | 0.0% | |
| 60.00% | 5 | 3.5 | 704 | 10,793 | 50.0% | 66.7% | |
| 20.00% | 5 | 2.1 | 744 | 10,283 | 0.0% | 50.0% | |
| 40.00% | 5 | 1.5 | 824 | 14,030 | 0.0% | 50.0% | |
| 20.00% | 5 | 4.5 | 620 | 12,794 | 0.0% | 25.0% | |
| 20.00% | 5 | 2.5 | 740 | 11,034 | 0.0% | 25.0% | |
| 60.00% | 5 | 1.6 | 801 | 9,670 | 50.0% | 66.7% | |
| 0.00% | 5 | 1.8 | 888 | 11,963 | 0.0% | 0.0% | |
| 40.00% | 5 | 2.0 | 760 | 15,393 | 0.0% | 40.0% | |
| 40.00% | 5 | 4.5 | 850 | 13,858 | 0.0% | 40.0% | |
| 40.00% | 5 | 4.8 | 703 | 10,364 | 50.0% | 0.0% | |
Help us maintain accuracy! If you notice incorrect stats, missing data, or any issues, your feedback directly improves the quality of our data for the entire community.
瘟疫之源 vs 寒冰射手 - 常见问题
在英雄联盟中，瘟疫之源对寒冰射手表现如何？
瘟疫之源以50.3%的胜率赢得瘟疫之源 vs 寒冰射手的对决，而寒冰射手为49.7%，相差0.6个百分点。该数据基于26.11版本的346场近期排位赛。
在前期，瘟疫之源对寒冰射手表现如何？
在前期，寒冰射手对瘟疫之源占有优势，胜率为53.4%对46.6%。寒冰射手玩家应该在前15分钟通过积极换血和控线来扩大线上优势。
在后期，瘟疫之源对寒冰射手表现如何？
在后期，瘟疫之源以52.6%对47.4%的胜率主导瘟疫之源 vs 寒冰射手的对决。瘟疫之源在25分钟后的团战和目标争夺中成长更强。
谁赢得瘟疫之源 vs 寒冰射手的对决？
瘟疫之源在英雄联盟26.11版本中以50.3%的胜率赢得对寒冰射手的对决。0.6个百分点的优势意味着根据346场分析的比赛，瘟疫之源在这个线上对决中slightly占优。
对抗寒冰射手的最佳瘟疫之源出装是什么？
对抗寒冰射手的最佳瘟疫之源出装包括无尽之刃, 海克斯镜片 C44, 猎魔人弩箭 with 狂战士胫甲。This build achieves a 100.0% win rate in the matchup. 查看上方的对决分析了解完整的出装路线和顺序。
对抗寒冰射手的最佳瘟疫之源符文是什么？
对抗寒冰射手的最佳瘟疫之源符文使用精密主系和巫术副系。This rune setup achieves a 64.3% win rate in the 瘟疫之源 vs 寒冰射手 matchup. 查看上方对决比较中的完整符文分析。
瘟疫之源克制寒冰射手吗？
是的，瘟疫之源对寒冰射手有利，胜率为50.3%。根据当前26.11版本数据，瘟疫之源在线上slightly edges out寒冰射手。
如何用瘟疫之源对战寒冰射手？
当瘟疫之源对战寒冰射手时，利用你的统计优势在有利的窗口期积极换血。Play safe early and scale into your power spikes where you outperform 寒冰射手. 使用该对决专用的推荐装备和符文以获得最佳效果。